NL167434C - METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ALDOSE REDUCTASE INHIBITORY EFFECT AND METHOD FOR PREPARING A SPIRO-HYDANTOINE, SUITABLE FOR USE IN THE FOREGOING METHOD - Google Patents

METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ALDOSE REDUCTASE INHIBITORY EFFECT AND METHOD FOR PREPARING A SPIRO-HYDANTOINE, SUITABLE FOR USE IN THE FOREGOING METHOD

Info

Publication number
NL167434C
NL167434C NL7711358.A NL7711358A NL167434C NL 167434 C NL167434 C NL 167434C NL 7711358 A NL7711358 A NL 7711358A NL 167434 C NL167434 C NL 167434C
Authority
NL
Netherlands
Prior art keywords
preparing
hydantoine
spiro
manufacturing
inhibitory effect
Prior art date
Application number
NL7711358.A
Other languages
Dutch (nl)
Other versions
NL7711358A (en
NL167434B (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer filed Critical Pfizer
Publication of NL7711358A publication Critical patent/NL7711358A/en
Publication of NL167434B publication Critical patent/NL167434B/en
Application granted granted Critical
Publication of NL167434C publication Critical patent/NL167434C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
NL7711358.A 1976-10-18 1977-10-17 METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ALDOSE REDUCTASE INHIBITORY EFFECT AND METHOD FOR PREPARING A SPIRO-HYDANTOINE, SUITABLE FOR USE IN THE FOREGOING METHOD NL167434C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (3)

Publication Number Publication Date
NL7711358A NL7711358A (en) 1978-04-20
NL167434B NL167434B (en) 1981-07-16
NL167434C true NL167434C (en) 1981-12-16

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7711358.A NL167434C (en) 1976-10-18 1977-10-17 METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ALDOSE REDUCTASE INHIBITORY EFFECT AND METHOD FOR PREPARING A SPIRO-HYDANTOINE, SUITABLE FOR USE IN THE FOREGOING METHOD

Country Status (29)

Country Link
JP (3) JPS5353653A (en)
AR (1) AR220901A1 (en)
AT (1) AT356136B (en)
AU (1) AU504978B2 (en)
BG (1) BG28847A3 (en)
CA (1) CA1088945A (en)
CH (1) CH625511A5 (en)
DD (1) DD131931A5 (en)
DE (4) DE2759542C2 (en)
DK (1) DK150302C (en)
ES (1) ES463267A1 (en)
FI (1) FI62307C (en)
FR (1) FR2367754A1 (en)
GB (1) GB1566171A (en)
GR (1) GR70201B (en)
HK (1) HK53881A (en)
IE (1) IE45805B1 (en)
IL (1) IL53094A0 (en)
KE (1) KE3167A (en)
LU (1) LU78330A1 (en)
MX (1) MX4899E (en)
MY (1) MY8200157A (en)
NL (1) NL167434C (en)
NO (1) NO148453C (en)
NZ (1) NZ185358A (en)
PH (1) PH15639A (en)
PT (1) PT67164B (en)
SE (1) SE437024B (en)
YU (1) YU40821B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (en) * 1982-01-20 1983-12-12 Eisai Co Ltd Remedy containing hydantoin derivative
JPS59500617A (en) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド Hydantoin therapeutic agent
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
WO1986002647A1 (en) * 1984-10-30 1986-05-09 Pfizer Inc. Spiro-heteroazolones for treatment of diabetes complications
JPS61200991A (en) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk Novel spiro-3-heteroazolidine compound, production thereof, preventive and remedy for diabetic complication comprising same as active ingredient
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (en) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd Hydantoin derivative, salt and, production thereof and preventing and treating, agent for diabetic complication
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
JP2005523314A (en) 2002-04-18 2005-08-04 ユニバーシティ オブ バージニア パテント ファウンデーション Novel sodium channel blocking compounds
FR2955107B1 (en) 2010-01-08 2012-03-02 Servier Lab NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (en) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Process for the production of new, anticonvulsant spirohydantoins
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (en) * 1974-10-11 1976-05-20 Schering Ag NEW PYRIDINE DERIVATIVES
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
KE3167A (en) 1981-11-06
ATA745977A (en) 1979-09-15
FI773060A (en) 1978-04-19
FI62307C (en) 1982-12-10
DK150302C (en) 1987-09-28
JPS5534132B2 (en) 1980-09-04
GR70201B (en) 1982-08-31
NL7711358A (en) 1978-04-20
JPS607997B2 (en) 1985-02-28
NL167434B (en) 1981-07-16
FR2367754A1 (en) 1978-05-12
IE45805B1 (en) 1982-12-01
FI62307B (en) 1982-08-31
AR220901A1 (en) 1980-12-15
GB1566171A (en) 1980-04-30
JPS5940388B2 (en) 1984-09-29
DE2759542C2 (en) 1988-07-07
JPS5495575A (en) 1979-07-28
BG28847A3 (en) 1980-07-15
DE2746244A1 (en) 1978-04-20
MX4899E (en) 1982-12-14
PH15639A (en) 1983-03-11
HK53881A (en) 1981-11-13
AT356136B (en) 1980-04-10
NO148453C (en) 1983-10-12
YU40821B (en) 1986-06-30
AU504978B2 (en) 1979-11-01
CH625511A5 (en) 1981-09-30
CA1088945A (en) 1980-11-04
IL53094A0 (en) 1977-12-30
PT67164A (en) 1977-11-01
SE7711053L (en) 1978-04-19
LU78330A1 (en) 1979-06-01
SE437024B (en) 1985-02-04
MY8200157A (en) 1982-12-31
DE2759543C2 (en) 1987-04-09
NO773548L (en) 1978-04-19
DE2759927C2 (en) 1986-12-04
DD131931A5 (en) 1978-08-09
DK461377A (en) 1978-04-19
DE2746244C2 (en) 1983-05-19
FR2367754B1 (en) 1982-07-09
AU2943177A (en) 1979-04-12
PT67164B (en) 1979-03-20
NO148453B (en) 1983-07-04
ES463267A1 (en) 1978-07-16
IE45805L (en) 1978-04-18
JPS5353653A (en) 1978-05-16
NZ185358A (en) 1979-06-08
YU244277A (en) 1982-08-31
JPS5495570A (en) 1979-07-28
DK150302B (en) 1987-02-02

Similar Documents

Publication Publication Date Title
NL167434C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ALDOSE REDUCTASE INHIBITORY EFFECT AND METHOD FOR PREPARING A SPIRO-HYDANTOINE, SUITABLE FOR USE IN THE FOREGOING METHOD
NL167688C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH BLOOD PRESSURE-REDUCING ACTION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING PROCESS
NL174348B (en) METHOD FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE FOREGOING METHOD
NL930049I2 (en) A method of preparing or manufacturing a pharmaceutical preparation with anti-tumor activity and a method of preparing a platinum coordination compound suitable for use in the aforementioned method.
NL163525C (en) METHOD FOR POLYMERIZING 1-OLEGINS AND METHOD FOR PREPARING A CATALYST SUITABLE FOR USE IN THE FOREGOING METHOD
NL168220C (en) METHOD FOR BINDING BIOLOGICALLY ACTIVE PROTEINS, AND A METHOD FOR PREPARING A COMPOUND, SUITABLE FOR USE IN THE FOREGOING METHOD
NL178863C (en) METHOD FOR PREPARING A GIPS-CONTAINING ACCELERATOR FOR USE IN THE MANUFACTURE OF GYPLATE, AND GIPPLATE MADE USING THIS ACCELERATOR
NL177747C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTI-THROMBOSIS ACTION, AND PROCESS FOR PREPARING NŸ2-ARYLSULPHONYL-L-ARGININE DERIVATIVES USABLE FOR USE IN SUCH PREPARATIONS.
NL169076B (en) METHOD FOR PREPARING OR MANUFACTURING PHARMACOLOGICAL PREPARATIONS WITH ANALGETIC AND ANTIPYRETIC ACTION, AND METHOD FOR PREPARING MEDICINAL COMPOUNDS, SUITABLE FOR USE IN SUCH PREPARATIONS
NL173643C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL154505B (en) PROCESS FOR PREPARING A PREPARATION WITH HERBICIDE ACTION USING THIS PROCEDURE FORMED PREPARATION OBTAINED AND PROCEDURE FOR PREPARING A HERBICIDE COMPOUND, SUITABLE FOR USE IN THE SAID PROCEDURE.
NL161451B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCEDURE FOR PREPARING A COMPOUND, SUITABLE FOR USE IN THE PREPARATION OF THIS PREPARATION.
NL7413682A (en) PROCEDURE FOR THE MANUFACTURE OF CAST OBJECTS WITH A STONE CRYSTAL STRUCTURE AND CAST FORM SUITABLE FOR USE THEREOF, AND THE OBJECTS SO MANUFACTURED.
NL180978C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH SECRETORIC AND / OR ANTI-COUGHTING ACTION, AND A METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL178061C (en) METHOD AND APPARATUS FOR MANUFACTURING CASTS USING VACUUM, AND FORMING TO BE USED IN THE METHOD
NL171707C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH HYPOGLYCAEMIC ACTION AND METHOD FOR PREPARING A MEDICINAL COMPOUND, SUITABLE FOR USE IN PREVIOUS METHOD
NL168229C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL OR VETERINARY PREPARATION WITH ANTHELMINTIC ACTION AND METHOD FOR PREPARING A COMPOUND WITH ANTHELMINTIC ACTION SUITABLE FOR USE IN THE PREVIOUS METHOD
NL177918C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ADRENERGICLY BLOCKING ACTION USING CARBOSTYRIL DERIVATIVES, AND METHOD FOR PREPARING CARBOSTYRIL DERIVATIVES, SUITABLE FOR SUCH AMOUNT OF THE SAME
NL169479B (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL OR VETERINARY PREPARATION WITH ANTHELMINTIC ACTION AND METHOD FOR PREPARING A COMPOUND WITH ANTHELMINTIC ACTION SUITABLE FOR USE IN THE FOREGOING METHOD
NL163514C (en) PROCESS FOR PREPARING A PREPARATION WITH ANTI-ALLERGIC ACTION BASED ON 1-OXO-1H-PYRIMIDOŸ1,2-AŸ QUINOLINE-2-CARBONIC ACID DERIVATIVES AND PROCESS FOR PREPARING A MEDICINAL COMPOUND SUITABLE FOR USE IN THE PREPARATION OF THE SAID PREPARATION.
NL7713595A (en) CORTICOIDES, METHOD FOR PREPARING THEREOF AND METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-PHOGISTICAL ACTION.
NL154420B (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH BLOOD SUGAR MIRROR REDUCING ACTION, USING THIS FORMED MEDICINAL PRODUCT, AND PROCESS FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING.
NL179110B (en) METHOD FOR PREPARING OR MANUFACTURING PHARMACEUTICAL PREPARATIONS WITH ANTI-ALLERGY ACTION, AND METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE FOREGOING PROCESS
NL7701655A (en) 1-ARYL- (1H) -QINAZOLONE-4-DERIVATIVES, METHOD FOR THE PREPARATION OF THESE DERIVATIVES, PHARMACECUTICAL PREPARATION WITH THESE DERIVATIVES AND METHOD OF USE THEREOF.
NL169592C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT AND METHOD FOR PREPARING A MEDICINAL COMPOUND SUITABLE FOR USE IN THE PREPARATION OF THIS MEDICINAL PRODUCT

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee